Mechanisms of coronary microvascular adaptation to obesity
Open Access
- 1 September 2009
- journal article
- review article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 297 (3), R556-R567
- https://doi.org/10.1152/ajpregu.90817.2008
Abstract
The metabolic syndrome (MetS) is associated with clustering of cardiovascular risk factors in individuals that may greatly increase their risk of developing coronary artery disease. Obesity and related metabolic dysfunction are the driving forces in the prevalence of MetS. It is believed that obesity has detrimental effects on cardiovascular function, but its overall impact on the vasomotor regulation of small coronary arteries is still debated. Emerging evidence indicates that in obesity coronary arteries adapt to hemodynamic changes via maintaining and/or upregulating cellular mechanism(s) intrinsic to the vascular wall. Among other factors, endothelial production of cyclooxygenase-2-derived prostacyclin and reactive oxygen species, as well as increased nitric oxide sensitivity and potassium channel activation in smooth muscle cells, have been implicated in maintaining coronary vasodilator function. This review aims to examine studies that have been primarily focused on alterations in coronary vasodilator function in obesity. A better understanding of cellular mechanisms that may contribute to coronary microvascular adaptation may provide insight into the sequence of pathological events in obesity and may allow the harnessing of these effects for therapeutic purposes.Keywords
This publication has 119 references indexed in Scilit:
- Leptin-induced endothelial dysfunction in obesityAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Cardiac Remodeling in ObesityPhysiological Reviews, 2008
- Blood Pressure and Vascular Effects of Leptin in HumansMetabolic Syndrome and Related Disorders, 2007
- Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxideBritish Journal of Pharmacology, 2007
- Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trialsBMJ, 2006
- Impaired small‐conductance Ca2+‐activated K+ channel‐dependent EDHF responses in Type II diabetic ZDF ratsBritish Journal of Pharmacology, 2006
- Cyclo‐oxygenase‐2: pharmacology, physiology, biochemistry and relevance to NSAID therapyBritish Journal of Pharmacology, 1999
- Vascular wall reactivity in conductance and resistance arteries: differential effects of insulin resistanceCanadian Journal of Physiology and Pharmacology, 1998
- The haemodynamics of obesity: a theoretical analysisJournal of Hypertension, 1992
- Hydrogen peroxide elicits activation of bovine pulmonary arterial soluble guanylate cyclase by a mechanism associated with its metabolism by catalaseBiochemical and Biophysical Research Communications, 1987